Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.

MLA

Jehuda-Cohen, T., et al. “Polyclonal B-Cell Activation Reveals Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) in HIV-1-Seronegative Individuals.” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 10, May 1990, pp. 3972–76. EBSCOhost, https://doi.org/10.1073/pnas.87.10.3972.

APA

Jehuda-Cohen, T., Slade, B. A., Powell, J. D., Villinger, F., De, B., Folks, T. M., McClure, H. M., Sell, K. W., & Ahmed-Ansari, A. (1990). Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proceedings of the National Academy of Sciences of the United States of America, 87(10), 3972–3976. https://doi.org/10.1073/pnas.87.10.3972

Chicago

Jehuda-Cohen, T, B A Slade, J D Powell, F Villinger, B De, T M Folks, H M McClure, K W Sell, and A Ahmed-Ansari. 1990. “Polyclonal B-Cell Activation Reveals Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) in HIV-1-Seronegative Individuals.” Proceedings of the National Academy of Sciences of the United States of America 87 (10): 3972–76. doi:10.1073/pnas.87.10.3972.